Evaluation of the anticonvulsant activity of 6-(4-chlorophenyoxy)-tetrazolo[5,1-a]phthalazine in various experimental seizure models in mice

[1]  A. Falcão,et al.  The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs. , 2009, Methods and findings in experimental and clinical pharmacology.

[2]  K. Chai,et al.  Synthesis and Anticonvulsant Activity of 6‐Alkoxy‐[1,2,4]Triazolo[3,4‐a]Phthalazines , 2009, Chemical biology & drug design.

[3]  H. Piao,et al.  Characterization of the anticonvulsant activity of doxepin in various experimental seizure models in mice , 2009, Pharmacological reports : PR.

[4]  S. Fidecka,et al.  Role of nitric oxide in the development of tolerance to diazepam-induced motor impairment in mice. , 2008, Pharmacological reports : PR.

[5]  M. El-Enany,et al.  Synthesis, analgesic, anti-inflammatory, and antimicrobial activity of some novel pyrimido[4,5-b]quinolin-4-ones. , 2008, Bioorganic & medicinal chemistry.

[6]  J. Chen,et al.  Synthesis and anticonvulsant evaluation of 4-(4-alkoxylphenyl)-3-ethyl-4H-1,2,4-triazoles as open-chain analogues of 7-alkoxyl-4,5-dihydro[1,2,4]triazolo[4,3-a]quinolines. , 2007, Bioorganic & medicinal chemistry.

[7]  A. V. Karnik,et al.  Synthesis and in vitro antibacterial activity of novel heterocyclic derivatives of 18-nor-equilenin. , 2006, European journal of medicinal chemistry.

[8]  H. Kupferberg.  Strategies for identifying and developing new anticonvulsant drugs , 1992, Pharmaceutisch Weekblad.

[9]  Yaseen A Al-Soud,et al.  Synthesis and properties of new substituted 1,2,4-triazoles: potential antitumor agents. , 2003, Bioorganic & medicinal chemistry.

[10]  ZH Israili,et al.  Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension , 2000, Journal of Human Hypertension.

[11]  W. Löscher,et al.  New visions in the pharmacology of anticonvulsion. , 1998, European journal of pharmacology.

[12]  P. Kadaba,et al.  Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents , 1997 .

[13]  L. Stein,et al.  Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid Co 3-0593 , 1997, Psychopharmacology.

[14]  B. Bourgeois.  New antiepileptic drugs. , 1998, Current opinion in pediatrics.

[15]  E. Perucca,et al.  The new generation of antiepileptic drugs: advantages and disadvantages. , 1996, British journal of clinical pharmacology.

[16]  I. Leppik.  Antiepileptic Drugs in Development: Prospects for the Near Future , 1994, Epilepsia.

[17]  M. T. Medina,et al.  Progress in Mapping Human Epilepsy Genes , 1994, Epilepsia.

[18]  C. Martini,et al.  Studies on annelated 1,4-benzothiazines and 1,5-benzothiazepines. VII. Synthesis and inhibition of benzodiazepine receptor binding of some 4,5-dihydro-tetrazolo[5,1-d]-1,5-benzothiazepines and 5-phenyl-s-triazolo[3,4-d]-1,5-benzothiazepines. , 1993, Farmaco.

[19]  K. Gale,et al.  GABA and epilepsy: basic concepts from preclinical research. , 1992, Epilepsia.

[20]  H. Nagaya,et al.  The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazol-induced seizures , 1989, Brain Research.

[21]  R. Olsen.  GABA‐Benzodiazepine‐Barbiturate Receptor Interactions , 1981, Journal of neurochemistry.

[22]  W. Lo¨scher.  3-Mercaptopropionic acid: Convulsant properties, effects on enzymes of the γ-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine , 1979 .

[23]  W. Löscher.  3-Mercaptopropionic acid: convulsant properties, effects on enzymes of the gamma-aminobutyrate system in mouse brain and antagonism by certain anticonvulsant drugs, aminooxyacetic acid and gabaculine. , 1979, Biochemical pharmacology.

[24]  M. A. Hamilton,et al.  Trimmed Spearman-Karber Method for Estimating Median Lethal Concentrations in Toxicity Bioassays , 1977 .